SCHEMBL3499703

SCHEMBL3499703

Cc1[nH]nc(C(N)(CN)c2n[nH]c(C)c2I)c1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13162512 0.71 NR2F2 (0.38) —
Hydrochloric Acid SCHEMBL3502520 0.68 AKT2 (0.53) —
SCHEMBL3500224 0.63 MAPT (0.38) —
SCHEMBL1205854 0.62 — —
Hydrochloric Acid SCHEMBL3500648 0.61 MAPT (0.37) —
SCHEMBL13682952 0.58 — —
SCHEMBL14046019 0.58 — —
SCHEMBL20844025 0.58 — —
SCHEMBL8804109 0.57 P2RX7 (0.40) —
SCHEMBL25291229 0.55 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144793-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS AC IMMUNE SA (CH) 2010-06-10 — — US disclosed
EP-2121619-A2 COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS AC Immune S.A. (CH) 2009-11-25 — — EP disclosed
WO-2008061796-A2 COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS AC IMMUNE SA (CH) 2008-05-29 — — WO disclosed
Send feedback